World Video | Defence | Foreign Affairs | Natural Events | Trade | NZ in World News | NZ National News Video | NZ Regional News | Search

 


Testing for Counterfeit Drug Tool Screening Begins in Africa

Field Testing for Rapid Counterfeit Drug Screening Tool Begins in Africa

Initial testing targets ability to identify fake & poor quality malaria medicines

Rockville, Md., June 4, 2014 — Field testing for a new screening tool intended to help quickly detect counterfeit and poor quality medicines has begun at the U.S. Pharmacopeial Convention’s (USP) Center for Pharmaceutical Advancement and Training (CePAT), located in Ghana.

The new screening device, called CD-3+, was launched by the U.S. Food and Drug Administration in April 2013.

“CD-3+ is, rapid, portable device that requires little training for effective use, potentially changing the way counterfeit and poor quality products are detected and resulting in substantial cost savings over more expensive alternatives,” says Patrick Lukulay, Ph.D., vice president of Global Health Impact Programs at USP and director of the Promoting the Quality of Medicines program (PQM). “The testing now underway in Ghana will provide a side-by-side comparison of CD-3+ with other existing screening devices to assess the capability to discriminate between authentic and substandard medicines.”

Specifically, the tests conducted in the field and at CePAT will evaluate CD-3+ in the screening of two malaria treatments commonly used in Sub-Saharan Africa. A total of 200 test samples are being collected from sites across Ghana through acollaborative partnership between USP and the Ghana’s Food and Drug Authority. Results from the first field study are expected in September 2014.

“Field tests such as these will not only help us determine complementary advantages of the tools under evaluation, but will also help identify potential design improvements to CD-3+ to enable the development of a more robust, more portable and even easier to use tool,” says Leigh Verbois, director, Asia Pacific Office, Office of International Programs at U.S. FDA.

The U.S. FDA was responsible for training personnel on how to properly use CD-3+ at CePAT and other test sites.

Testing is being conducted under an agreement between FDA and the U.S. Agency for International Development (USAID), which funds PQM, operated by USP. Funding for the activity has been provided by the Skoll Global Threats Fund. Other partners include the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC).

“As a development agency, USAID is well-positioned for in-country capacity building such as this,” says Anthony Boni, who leads PQM on USAID’s side through its Office of Health Systems in the Bureau for Global Health. “The presence of infrastructure as well as established relationships with the Ghana FDA provided an excellent platform for the field-testing of CD-3+ in Ghana.”

Since 2008, USAID, through the U.S. President’s Malaria Initiative (PMI) Ghana, has provided USP with US$1,470,000, specifically to strengthen the capacity of the Ghana FDA for the quality assurance of medicines in Ghana.

The tests being conducted in Ghana will evaluate CD-3+ in complementing GPHF’s Minilab™ (thin-layer chromatography) and Thermo Scientific’s TruScan™ (hand-held Raman spectrometer), evaluating counterfeit detection for two commonly used artemisinin-based combination therapies (ACTs) for malaria treatment in Sub-Saharan Africa: artemether + lumefantrine (AR-LU) and artesunate + amodiaquine (AS-AQ).

ENDS

© Scoop Media

 
 
 
 
 
World Headlines

 

UK Labour Statement: The Shooting Of MP Jo Cox

Jeremy Corbyn MP, Leader of the Labour Party said: “The whole of the Labour Party and Labour family - and indeed the whole country - will be in shock at the horrific murder of Jo Cox today. Jo had a lifelong record of public service and a deep commitment to humanity." More>>

ALSO:

Wellington.Scoop: Rainbow Colours On MFC In Sympathy For Florida Killings
Wellington’s Michael Fowler Centre will be lit in colours of the rainbow Monday as a gesture of support for the LGBTI victims of the Pulse nightclub attack in Orlando, Florida. More>>

ALSO:

Gordon Campbell: On How Obama’s Supreme Court Choice Says Everything (Bad) About His Presidency

Nothing has epitomised the presidency of Barack Obama quite like his Supreme Court nominees. Time and again, Republican presidents will blithely nominate right wing ideological extremists (Antonin Scalia, Samuel Alito, Clarence Thomas) who only sometimes misfire and turn out to be liberals in disguise (David Souter). Yet Obama has consistently skipped over the judicially qualified liberals and gone for a succession of centrists... More>>

ALSO:

Turkey: UN Secretary-General On The Terrorist Bombing In Ankara

The Secretary-General condemns the terrorist attack in Ankara earlier today. According to the latest reports, the explosion in the Kizilay district killed and wounded dozens of people. More>>

ALSO:

Five Years On: Fukushima And New Zealand

Science Media Centre: It was the worst nuclear event since Chernobyl. In the wake of the 2011 Tōhoku earthquake and tsunami, a crippled Japanese nuclear powerplant went into meltdown, and the world watched as emergency workers scrambled to shut down and contain the reactors. More>>

ALSO:

UNICEF: 1 In 3 Syrian Children Has Grown Up Knowing Only Crisis

An estimated 3.7 million Syrian children – 1 in 3 of all Syrian children - have been born since the conflict began five years ago, their lives shaped by violence, fear and displacement, according to a UNICEF report. This figure includes more than 151,000 children born as refugees since 2011. More>>

ALSO:

Franklin Lamb: Syria’s Truce Bodes Well For Salvaging Our Cultural Heritage

The tentative cessation of hostilities in Syria, which came into effect on 2/28/2016, brokered by Washington and Moscow, is only in its second week... It is well documented that there have been daily incidents of artillery shelling, airstrikes and clashes. Yet, for the nearly 12 million displaced civilians, half of Syria’s population, it’s a much welcomed respite. More>>

Get More From Scoop

 
 
 
 
 
World
Search Scoop  
 
 
Powered by Vodafone
NZ independent news